(Q35717112)

English

Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study

scientific article published on 10 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study (English)

1 reference

Europe PubMed Central

9 August 2017

People's Republic of China

0 references

author name string

Jianhua Wang

1

1 reference

Europe PubMed Central

9 August 2017

Mei Shi

2

1 reference

Europe PubMed Central

9 August 2017

Yuesheng Hsia

3

1 reference

Europe PubMed Central

9 August 2017

Shanquan Luo

4

1 reference

Europe PubMed Central

9 August 2017

Lina Zhao

5

1 reference

Europe PubMed Central

9 August 2017

Man Xu

6

1 reference

Europe PubMed Central

9 August 2017

Feng Xiao

7

1 reference

Europe PubMed Central

9 August 2017

Xuehai Fu

8

1 reference

Europe PubMed Central

9 August 2017

Jianping Li

9

1 reference

Europe PubMed Central

9 August 2017

Bin Zhou

10

1 reference

Europe PubMed Central

9 August 2017

Xiaoli Long

11

1 reference

Europe PubMed Central

9 August 2017

publication date

10 January 2012

1 reference

Europe PubMed Central

9 August 2017

Radiation Oncology

1 reference

Europe PubMed Central

9 August 2017

7

1 reference

Europe PubMed Central

9 August 2017

2

1 reference

Europe PubMed Central

9 August 2017

https://scigraph.springernature.com/pub.10.1186/1748-717x-7-2

0 references

Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Modern treatment for nasopharyngeal carcinoma: current status and prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Prognostic Factors Affecting the Outcome of Nasopharyngeal Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

12 July 2018

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy.

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break.

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Prognostic significance of tumor volume in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-2

21 January 2018

Chemoradiation in nasopharyngeal carcinoma: a 6-year experience in Tehran cancer institute.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

25 September 2018

The relationship between nasopharyngeal carcinoma tumor volume and TNM T-classification: a quantitative analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

25 September 2018

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3269351

25 September 2018

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22233756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22233756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasopharyngeal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22233756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1748-717X-7-2

1 reference

Europe PubMed Central

9 August 2017

Dimensions Publication ID

0 references

release_xv2yxr3rhrexffjposuxvrq42e

1 reference

https://api.fatcat.wiki/v0/release/xv2yxr3rhrexffjposuxvrq42e

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35717112&oldid=1843256793"